Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients

Journal of Infection

Volumn 38, Issue 3, 1999, Pages 176-181

  Meynard, Jean Luc ^a   Barbut, Frédéric ^a   Guiguet, Marguerite ^b   Batisse, Dominique ^a   Lalande, Vaiérie ^a   Lesage, Danièie ^a   Guiard Schmid, Jean Baptiste ^a   Petit, Jean Claude ^a   Frottier, Jacques ^a   Meyohas, Marie Caroline ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CATHETER INFECTION; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; MYOSITIS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK FACTOR; SKIN INFECTION; UPPER RESPIRATORY TRACT INFECTION;

EID: 13044286789     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(99)90247-5     Document Type: Article

References (27)

1. Krumholz HM, Sande MA, Lo B. Community-acquired bacteremia in patients with acquired immmuno-deficiency syndrome: clinical presentation, bacteriology and outcome. Am J Med 1989; 86: 776-779.
2. Stein M. O'Sullivan P, Wachtel T, et al. Causes of death in persons with human immunodeficiency virus infection. Am J Med 1992; 93: 387-390.
3. Bernard E, Carles M, De Salvador F, Pradier C, Dellamonica P. 34th Interscience Conference on Antimicorobial Agents and C hemotherapy Abstract 1203: 4-7 October 1994, Orlando, Florida.
4. Hirschtick RE, Glassroth J, Jordans MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995; 333: 845-851.
5. Jan off EN, Breiman RF, Daley CL. Pneumococcal disease during HIV infection. Am Intern Med 1992; 117: 313-324.
6. Jacobson MA, Gellerman H, Chambers H. Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS related complex. Am J Med 1988; 85: 172-176.
7. Skoutelis AT, Murphy R, Mac Donell KB, Von Roenn JH, Sterkel CD. Phain JP. Indwelling central venous catheter infections in patients with acquired immunodeficiency syndrome. J AIDS 1990; 3: 335-342.
8. Fichtenbaum CJ, Woeltje KF, Powderly WG. Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: A case-control study. Clin Infect Dis 1994; 19: 417-422.
9. Baron AD, Hollander H. Pseudomonas aeruginosa bronchopulmonary infection in late human immuno-deficiency virus disease. Am Rev Respir Dis 1993; 148: 992-996.
10. Mendelson MH, Gurtman A, Szabo S, et al. Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin. Infect. Dis. 1994; 18: 886-895.
11. Kielhofner M, Atmar RL, Hamill RJ. Musher DM. Life threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis 1992; 14: 403-411.
12. Nelson MR Shanson DC, Barter GJ, et al. Pseudomonas septicaemia associated with HIV. AIDS 1991; 5: 761-763.
13. Dropulic LK, Leslie JM, Eldred LJ, Zenilman J, Sears CL. Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS. J Infect Dis 1995; 171: 930-937.
14. Brun-Buisson C, Abrouk E. Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis of central venous catheter-related sepsis: critical level of quantitative tip cultures. Arch Intern Med 1987; 147: 873-877.
15. U.S. Department of Health and Human Services. National nosocomial infection surveillance manual. Atlanta: Centers for Disease Control. January 1988.
16. Acar J, Bergogne-Berezin E, Chardon H. et al. Communiqué 1994. Path Biol 1994; 42: 1-8.
17. Pitt TL. A comparison of flagellar typing and phage typing as means of subdividing the O groups of Pseudomonas aeruginosa. J Med Microbiol 1981; 14: 261-270.
18. Franzetti F, Cernuschi M, Esposito R, Moroni M, Pseudomonas infections in patients with AIDS and AIDS related complex. J Intern Med 1992; 231: 437-443.
19. Pollack M: Pseudomonas aeruginosa. In: Mandell GL, Douglas RG, Bennet JE, eds. Principles and Practice of Infectious Diseases. 3rd ed. New York: Churchill Livingstone 1990: 1673-1691.
20. Young LS. The clinical challenge of infections due to Pseudomonas aeruginosa. Rev Infect Dis 1984; 6 (suppl 3): S603-607.
21. Bert F, Bruneau B, Lambert-Zechovsky N, Branger C. Etude épidémiologique de al sensibilité aux antibiotiques de P. aeruginosa. Path Biol 1994; 42: 491-497.
22. Richard P, Delangel MH, Merrien D, et al. Fluoroquinolone use and Fluoroquinolone resistance: is there an association. Clin Infect Dis 1994; 19: 54-59.
23. Hardy WD, Feinberg J, Finkelstein D. et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosalized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 3842-1847.
24. Bozzette SA, Sattler FR, Chiu J, et al. A controlled trial of early adjunctive treatment with corticosteroïds for Pneumocysits carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990; 323: 451-1457.
25. Bodey GP, Bolivar R, Fainstein V., Jajeda L. Infections caused by Pseudomonas. aeruginosa. Rev Infect Dis 1983; 5: 279-313.
26. Ellis M, Gupta S, Galant S, et al. Impaired neutrophil function in patients with AIDS or AIDS related complex: a comprehensive evaluation. Rev Infect Dis 1988; 158: 1268-1276.
27. 7 Lane HC, Masur H, Edgar LC, Whalen G, Rosk AH, Fauci AS. Abnormalities of β cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309: 453-458.